Medical Device Affairs Outsourcing Market Report 2026

Medical Device Affairs Outsourcing Market Overview

• Medical Device Affairs Outsourcing market size has reached to $5.45 billion in 2025 • Expected to grow to $7.65 billion in 2030 at a compound annual growth rate (CAGR) of 6.9% • Growth Driver: Surging Demand For Medical Devices Fuels Growth In The Medical Device Affairs Outsourcing • Market Trend: Innovative Solutions In Medical Device Affairs Outsourcing With The Rise Of Decentralized Clinical Trials • Europe was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Medical Device Affairs Outsourcing Market?

Medical device affairs outsourcing refers to the practice of hiring external firms or experts to manage regulatory compliance and quality assurance tasks related to medical devices. This outsourcing strategy is increasingly adopted by medical device companies to navigate the complex and evolving regulatory landscape, ensuring adherence to various international standards and regulations. The main services of medical device affairs outsourcing are regulatory writing and submissions, regulatory registration services, regulatory consulting, and others. Regulatory writing and submissions involve preparing and submitting the necessary documentation required by regulatory authorities to gain approval for medical devices. The various software includes cloud-based software and on-premise software. These are used by various end users such as pharmaceutical companies, medical technology companies, and others.

What Is The Medical Device Affairs Outsourcing Market Growth Forecast?

The medical device affairs outsourcing market size is expected to see strong growth in the next few years. It will grow to $7.65 billion in 2030 at a compound annual growth rate (CAGR) of 6.9%. The growth in the forecast period can be attributed to adoption of advanced regulatory software solutions, growth in outsourcing partnerships, increasing focus on strategic regulatory planning, expansion of post-market surveillance programs, integration of ai and analytics for regulatory efficiency. Major trends in the forecast period include increasing adoption of regulatory affairs outsourcing by medical device companies, rising demand for cloud-based compliance and management solutions, focus on streamlining clinical trial applications and regulatory submissions, growth in quality management system (qms) support services, enhanced post-market surveillance and risk assessment capabilities.

Global Medical Device Affairs Outsourcing Market Segmentation

1) By Service: Regulatory Writing And Submissions, Regulatory Registration Services, Regulatory Consulting, Other Services 2) By Software: Cloud Based Software, On Premise Software 3) By End User: Pharmaceutical Companies, Medical Technology Companies, Other End Users Subsegments: 1) By Regulatory Writing And Submissions: Clinical Trial Applications (CTAs), Investigational New Drug Applications (INDs), New Drug Applications (NDAs), Summary And Reports For Regulatory Agencies 2) By Regulatory Registration Services: Device Registration, Market Authorization Applications (MAAs), Product Listing And Establishment Registration 3) By Regulatory Consulting: Strategic Regulatory Planning, Regulatory Compliance Audits, Labeling And Advertising Compliance 4) By Other Services: Post-Market Surveillance, Training And Education, Quality Management System (QMS) Support, Risk Management And Assessment

What Is The Driver Of The Medical Device Affairs Outsourcing Market?

The increasing demand for medical devices is expected to propel the growth of the medical device affairs outsourcing market going forward. Medical devices are instruments, apparatuses, machines, or implants used to diagnose, treat, or prevent medical conditions. The increasing demand for medical devices is primarily due to improved treatment efficacy, enhanced patient outcomes, and expansion of healthcare facilities. Medical device affairs outsourcing helps streamline operations, strengthen compliance, and improve market outcomes, allowing companies to focus on innovation and growth while leveraging external expertise for critical functions. For instance, in April 2024, The Medicines and Healthcare products Regulatory Agency(MHRA), a UK-based government agency, the number of registered medical products with the MHRA increased from 2022 (around 2.25 million) to 2024 (around 3.25 million). Therefore, the increasing demand for medical devices is driving the medical device affairs outsourcing industry.

Key Players In The Global Medical Device Affairs Outsourcing Market

Major companies operating in the medical device affairs outsourcing market are IQVIA Holdings Inc, ICON PLC, PAREXEL International Corporation, Intertek Group PLC, Eurofins Scientific SE, SGS SA, TUV SUD AG, TUV Rheinland AG, UL Solutions Inc, BSI Group, RQM Plus LLC, NAMSA, Medpace Holdings Inc, WuXi AppTec Inc, Charles River Laboratories International Inc, Laboratory Corporation of America Holdings, Sterigenics International LLC, Pace Analytical Services LLC, Avania LLC, Qserve Group BV, IMed Consultancy Ltd, Global Regulatory Partners Inc, MedTech Review LLC, Clario Inc, ProPharma Group Inc, NSF Health Sciences LLC

Global Medical Device Affairs Outsourcing Market Trends and Insights

Major companies operating in the medical device affairs outsourcing market are looking to enhance decentralized clinical trials to enhance the efficiency and flexibility of clinical research, improve patient recruitment and retention, and streamline data collection and analysis processes. A decentralized clinical trial (DCT) refers to a clinical trial model that supports the medical device industry by providing specialized services that enhance the efficiency, compliance, and effectiveness of clinical trials, essential for bringing new medical devices to market. For instance, in March 2023, Syneos Health, a US-based company that provides contract research and commercial services to pharmaceuticals and biotechnology, launched a Decentralized Clinical Trial (DCT) Site Network. This aimed at enhancing the adoption and quality of decentralized clinical trials' commitment to advancing decentralized solutions in clinical trials, ultimately improving patient participation and trial outcomes. This integration supports the collection of robust evidence and real-world insights essential for successful commercialization strategies.

What Are Latest Mergers And Acquisitions In The Medical Device Affairs Outsourcing Market?

In June 2023, Arterex Medical, a US-based company that offers medical device contract manufacturing, acquired NextPhase Medical Devices LLC for an undisclosed amount. With this acquisition, Arterex is enhancing its manufacturing capabilities and positioning it for future growth in a competitive landscape. NextPhase Medical Devices LLC is a US-based company that offers medical device affairs outsourcing.

Regional Outlook

Europe was the largest region in the medical device affairs outsourcing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Medical Device Affairs Outsourcing Market?

The medical device affairs outsourcing includes revenues earned by entities by providing services such as data management services, compliance management, and documentation services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.